MedPath

A randomised controlled trial of an interactive decision aid for prostate cancer screening

Not Applicable
Completed
Conditions
PSA testing for prostate cancer.
Public Health - Health promotion/education
Public Health - Epidemiology
Cancer - Prostate
Registration Number
ACTRN12612000723886
Lead Sponsor
Professor Glenn Salkeld
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
1398
Inclusion Criteria

40-69 year old men living in Australia who have access to the internet and a reasonable command of the English language.

Exclusion Criteria

No access to the internet, insufficient English, younger than 40 years or older than 69 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: Decision quality as measured by MyDecisionQuality an eight point scale that encompasses dimensions of making a high quality health decision.[Baseline (after completion of interactive decision aid).]
Secondary Outcome Measures
NameTimeMethod
Secondary Outcome 1: The proportion of the intervention and control group who indicate they are more likely to visit their GP to discuss PSA testing after interacting with either the 'Pick Your Own' (PYO) or Fixed Attribute (control group) decision aids. (The PYO version is where participants choose, from a list of 10 attributes, the ones they think are important to them). This will be assessed in the online questionnaire by asking participants to indicate how likely they are to see their GP about PSA testing before and after they use the appropriate decision aid.[After interaction with the decision aid.]
© Copyright 2025. All Rights Reserved by MedPath